全文获取类型
收费全文 | 3908篇 |
免费 | 154篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 180篇 |
妇产科学 | 8篇 |
基础医学 | 346篇 |
口腔科学 | 1篇 |
临床医学 | 268篇 |
内科学 | 840篇 |
皮肤病学 | 10篇 |
神经病学 | 14篇 |
特种医学 | 266篇 |
外科学 | 181篇 |
综合类 | 799篇 |
预防医学 | 221篇 |
眼科学 | 1篇 |
药学 | 479篇 |
6篇 | |
中国医学 | 318篇 |
肿瘤学 | 106篇 |
出版年
2024年 | 5篇 |
2023年 | 33篇 |
2022年 | 72篇 |
2021年 | 122篇 |
2020年 | 109篇 |
2019年 | 75篇 |
2018年 | 84篇 |
2017年 | 105篇 |
2016年 | 127篇 |
2015年 | 143篇 |
2014年 | 326篇 |
2013年 | 315篇 |
2012年 | 323篇 |
2011年 | 319篇 |
2010年 | 225篇 |
2009年 | 187篇 |
2008年 | 166篇 |
2007年 | 197篇 |
2006年 | 145篇 |
2005年 | 115篇 |
2004年 | 92篇 |
2003年 | 85篇 |
2002年 | 62篇 |
2001年 | 62篇 |
2000年 | 65篇 |
1999年 | 68篇 |
1998年 | 53篇 |
1997年 | 58篇 |
1996年 | 29篇 |
1995年 | 40篇 |
1994年 | 37篇 |
1993年 | 32篇 |
1992年 | 31篇 |
1991年 | 25篇 |
1990年 | 29篇 |
1989年 | 23篇 |
1988年 | 13篇 |
1987年 | 15篇 |
1986年 | 16篇 |
1985年 | 13篇 |
1984年 | 12篇 |
1983年 | 6篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1967年 | 1篇 |
排序方式: 共有4104条查询结果,搜索用时 12 毫秒
61.
D. Reinhardt T. Zehmisch B. Becker M. Nagel-Hiemke 《European journal of pediatrics》1984,142(2):111-116
Among the possible mechanisms which may cause wheezing or asthmatic episodes a genetically determined -adrenoceptor blockade and a hyperresponsiveness of -andrenoceptors has been postulated. Evidence to support this hypothesis stems from an increased bronchial sensitivity to -blockers, a reduced formation of cyclic AMP in response to -adrenergic stimulation and enhanced -adrenergic responses in asthmatic subjects. The recent development of techniques for measuring the specific, high-affinity binding of radiolabeled -and -adrenergic antagonists made it possible to study - and -adrenoceptors in vitro. Based upon the assumption that a change in the number and/or affinity of adrenergic receptors might be a general phenomenon, we have performed - and -receptor binding studies on lymphocytes and platelets from wheezing infants and asthmatic children as well as of infants, children, and adults not suffering from these diseases.Using 125[I]-cyanopindolol (ICYP) and 3[H]-yohimbine (HYOH) as highly specific ligands for - and -adrenoceptors, the following results were obtained: (1) Lymphocytes and platelets from control subjects and asthamatics bound similar amounts of ICYP and HYOH and thus showed no differences either in the number or the affinity of - and -adrenoceptors. Lymphocytes and platelets of wheezing and nonwheezing infants also bound the same amounts of the radioligands. (2) In asthmatic children receiving 4×2 puffs salbutamol -adrenoceptor were down-regulated and this may mimic -adrenoceptor blockade. (3) When subjects were divided into four categories according to age (0–5, 5–10, 10–20 years, adults) the number of -adrenoceptor binding sites showed an age-dependent increase. The number and affinity of -adreneceptor binding sites on platelets was neither influenced by age nor disease.It is concluded that the - and -adrenoceptors of wheezing infants and asthmatic children at least on blood cells are normal. However the -adrenoceptors show an age-dependent maturation process, which may account for an unresponsiveness to -adrenoceptor agonists in wheezing infants.Supported by a grant from the Ministerium für Wissenschaft und Forschung, NRWPresented at the 19th Workshop for Pediatric Research, University of Göttingen, March 10–11, 1983 相似文献
62.
王彩云 《临床合理用药杂志》2014,(23):4-5
目的探讨硫酸镁辅助治疗重症支气管哮喘的临床效果。方法将医院2010-2013年收治的重症支气管哮喘患者129例按不同治疗方案分为对照组51例(给予支气管哮喘常规治疗)和试验组78例(常规治疗基础上给予硫酸镁静脉滴注),对2组患者治疗效果进行综合比较。结果经治疗后,试验组治疗总有效率为85.90%明显高于对照组的70.59%,差异有统计学意义(P〈0.05)。结论硫酸镁辅助治疗重症支气管哮喘效果显著,值得临床推广应用。 相似文献
63.
Mohammed H. Elkomy Shahira F. El Menshawe Rasha M. Kharshoum Amany M. Abdeltwab Raghda R. S. Hussein Doaa S. Hamad Izzeddin Alsalahat Heba M. Aboud 《Drug delivery》2022,29(1):2058
Asthma represents a globally serious non-communicable ailment with significant public health outcomes for both pediatrics and adults triggering vast morbidity and fatality in critical cases. The β2-adrenoceptor agonist, terbutaline sulfate (TBN), is harnessed as a bronchodilator for monitoring asthma noising symptoms. Nevertheless, the hepatic first-pass metabolism correlated with TBN oral administration mitigates its clinical performance. Likewise, the regimens of inhaled TBN dosage forms restrict its exploitation. Consequently, this work is concerned with the assimilation of TBN into a novel non-phospholipid nanovesicular paradigm termed novasomes (NVS) for direct and effective TBN pulmonary targeting. TBN-NVS were tailored based on the thin film hydration method and Box-Behnken design was applied to statistically optimize the formulation variables. Also, the aerodynamic pattern of the optimal TBN-NVS was explored via cascade impaction. Moreover, comparative pharmacokinetic studies were conducted using a rat model. TBN elicited encapsulation efficiency as high as 70%. The optimized TBN-NVS formulation disclosed an average nano-size of 223.89 nm, ζ potential of −31.17 mV and a sustained drug release up to 24 h. Additionally, it manifested snowballed in vitro lung deposition behavior in cascade impactor with a fine particle fraction of 86.44%. In vivo histopathological studies verified safety of intratracheally-administered TBN-NVS. The pharmacokinetic studies divulged 3.88-fold accentuation in TBN bioavailability from the optimum TBN-NVS versus the oral TBN solution. Concisely, the results proposed that NVS are an auspicious nanovector for TBN pulmonary delivery with integral curbing of the disease owing to target specificity. 相似文献
64.
目的观察碳酸氢钠雾化吸入在儿童支气管哮喘治疗中的作用。方法支气管哮喘急性发作患儿128例,随机分为观察组和对照组。对照组给予常规抗感染和激素、支气管扩张剂雾化吸入治疗,观察组在对照组基础上加用碳酸氢钠雾化吸入治疗。观察患儿治疗前后治疗效果以及外周血白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和肿瘤坏死因子-α(TNF-α)等的水平的变化。结果观察组显效率(59.4%)和总有效率(95.3%)均优于对照组(40.6%,82.8%),差异均有统计学意义(均P〈0.05)。观察组患儿症状和体征消失时间以及平均住院时间均显著短于对照组。两组患儿治疗后IL-6、IL-8和TNF-α等的水平均较治疗前显著降低,观察组降低更为显著,差异均有统计学意义(均P〈0.05)。结论碳酸氢钠雾化吸入治疗支气管哮喘可显著改善患儿症状和体征、缩短病程,并降低炎性因子的水平。 相似文献
65.
目的对1例支气管哮喘急性发作伴肺部感染的患者进行跟踪治疗,探讨患者在药物治疗中出现精神异常的原因。方法检索国内外关于可疑药物—孟鲁斯特钠等致精神异常的相关文献,整理相应的理论依据,为临床药物治疗提出合理建议。结果诱发精神异常等不良反应的药物较多,分析患者所用药物,锁定可疑药物孟鲁斯特钠和莫西沙星,予及时停用孟鲁司特钠,10 d后患者病情好转出院。结论有精神性疾病的哮喘患者使用孟鲁斯特钠时,需密切关注该药引起的精神异常,减少药害事件的发生。 相似文献
66.
目的:观察经支气管镜冷冻联合球囊扩张治疗结核性气道狭窄的疗效。方法收集青岛市立医院呼吸内科2013年11月~2014年11月收治的28例支气管结核性气道狭窄患者的临床资料,随机分成对照组与治疗组。对照组行球囊扩张治疗,治疗组行冷冻联合球囊扩张治疗,观察比较两组所需扩张次数。结果对照组平均扩张(4.92±0.79)次,治疗组平均扩张(2.69±0.95)次;两组并发症发生率比较,差异无统计学意义(P>0.05)。结论冷冻联合球囊扩张治疗结核性气道狭窄安全、有效。 相似文献
67.
目的观察雾化吸入布地奈德和特布他林对门诊轻、中急性发作期支气管哮喘患者的疗效。方法48例急性发作期支气管哮喘患者随机分为治疗组(26例)和对照组(22例)。治疗组每天雾化吸入布地奈德和特布他林雾化液7d,7d后吸入布地奈德气雾剂;对照组吸入布地夺德气雾剂和沙丁胺醇气雾剂(分别增加2次的剂量);均于治疗前和治疗后第3、7和14d给予症状评分。结果治疗组治疗后第3、7d症状评分较对照组明显降低,但第14d两组无明显差异。结论雾化吸入布地奈德和特布他林起效快,可为门诊轻、中度急性发作期哮喘的首选给药方法。 相似文献
68.
目的探讨孟鲁司特联合布地奈德治疗哮喘的临床效果。方法选择江苏大学附属人民医院2006年11月至2010年11月支气管哮喘患者100例,随机分为观察组和对照组。对照组给予常规治疗,同时给予布地奈德雾化吸入,观察组在对照组治疗基础上给予孟鲁司特口服。测定两组患者治疗前后肺功能。结果观察组治疗后FEV1/FVC%和PEF分别与对照组治疗后比较,差异有统计学意义(P<0.05);观察组咳嗽、胸闷、喘息缓解时间与对照组比较,差异有统计学意义(P<0.05);观察组白天和夜间发作次数分别与对照组比较,差异有统计学意义(P<0.05)。结论孟鲁司特联合布地奈德能够显著改善哮喘发作患者临床症状,改善患者肺功能,临床效果显著。 相似文献
69.
表面皮质激素吸入治疗儿童哮喘剂量的探讨 总被引:13,自引:0,他引:13
目的探讨我国哮喘儿童吸入皮质激素的疗效及安全性。方法研究50例间歇发作型及轻度持续发作型哮喘儿童吸入不同剂量(200~1200μg/d)皮质激素(二丙酸倍氯松,BDP)的肺功能、气道高反应性及下丘脑-垂体-肾上腺轴(HPAA)功能的变化。将50例哮喘患儿随机分为5组(每组10例),分别吸入安慰剂及BDP200,400,800,1200μg/d。结果经过3个月的治疗,各治疗组的第1秒用力呼气容积(FEV1),最高呼气流速(PEF)及PD20-FEV1均显著升高,而对照组则无明显变化。治疗前后各组患儿的血浆ACTH及血清皮质醇基础值均无明显变化,血浆皮质醇对ACTH刺激的反应值在对照组及BDP200μg组无明显变化,而在BDP≥400μg/d时则明显下降。结论200μg/d的BDP能有效地改善哮喘儿童的肺功能,降低气道高反应性,但当剂量≥400μg/d时,则可能引起血皮质醇对ACTH刺激的反应性抑制。临床上使用BDP吸入疗法治疗间歇发作型及轻度持续发作型儿童哮喘时,尽可能将剂量控制在每日400μg以下 相似文献
70.
Takashi Nishihara Yutaro Okamoto Hideo Ishikawa Naoki Omachi Yoshiaki Yoshikawa Kenichiro Ishida Masayasu Toratani Mitsuo Ohnishi 《Radiology Case Reports》2022,17(10):3686
A 58-year-old woman with bronchiectasis presented with massive hemoptysis and severe respiratory failure, which required long-term extracorporeal membrane oxygenation with continuous heparin infusion. Bronchial artery embolization using hydrogel coils, which provide a greater volume occlusion than bare platinum coils, was performed; hemoptysis stopped and she fully recovered. No recanalization was observed on follow-up computed tomography angiography 2 months postbronchial artery embolization, and there had been no recurrence of bleeding at the time of this report (at least 6 months). Although continuous anticoagulation during extracorporeal membrane oxygenation might hinder complete vessel occlusion by metallic coils or induce early recanalization (because the homeostatic mechanism of coils depends on the patient''s coagulability), our experience showed that bronchial artery embolization using hydrogel coils was effective and safe. Additionally, this case presents a successful example of anticoagulation management for patients with hemoptysis on extracorporeal membrane oxygenation who undergo bronchial artery embolization using coils. 相似文献